Search

everythinglearnresearchcommunity

for

Search:↓

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Testosterone may influence COVID-19 severity and outcomes.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Mechanical stress contributes to hair loss in androgenetic alopecia.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride reduces prostate bleeding by affecting blood vessel growth.